Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to $1.9 million.

  • Ekso Bionics Holdings' Accumulated Expenses fell 227.85% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 227.85%. This contributed to the annual value of $2.4 million for FY2024, which is 1171.17% down from last year.
  • As of Q3 2025, Ekso Bionics Holdings' Accumulated Expenses stood at $1.9 million, which was down 227.85% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Ekso Bionics Holdings' Accumulated Expenses registered a high of $3.0 million during Q1 2025, and its lowest value of $1.3 million during Q2 2021.
  • Its 5-year average for Accumulated Expenses is $2.0 million, with a median of $2.0 million in 2024.
  • Per our database at Business Quant, Ekso Bionics Holdings' Accumulated Expenses plummeted by 1980.24% in 2024 and then surged by 6606.94% in 2025.
  • Over the past 5 years, Ekso Bionics Holdings' Accumulated Expenses (Quarter) stood at $2.3 million in 2021, then decreased by 0.91% to $2.3 million in 2022, then rose by 16.94% to $2.7 million in 2023, then fell by 11.71% to $2.4 million in 2024, then decreased by 17.94% to $1.9 million in 2025.
  • Its Accumulated Expenses stands at $1.9 million for Q3 2025, versus $1.8 million for Q2 2025 and $3.0 million for Q1 2025.